J Breast Cancer.  2009 Dec;12(4):272-277. 10.4048/jbc.2009.12.4.272.

Arm Sentinel Lymph Node Detection for Preserving the Arm Lymphatic System

• Lee SK
• Choi JH
• Lim HI
• Kim WW
• Kim S
• Choe JH
• Lee JE
• Kim JH
• Kim JS
• Nam SJ
• Yang JH

• KMID: 2175519
• DOI: http://doi.org/10.4048/jbc.2009.12.4.272

Abstract

PURPOSE
The objective of arm sentinel lymph node (SLN) detection were to identify the presence of different drainage tracts of the breast and arm lymphatics and eventually to prevent lymphedema after an axillary procedure. METHODS: Twenty one patients underwent surgery for breast cancer, with arm SLN detection, from March to July 2008 at Samsung Medical Center. We used the (99)Tc-tin colloid isotope in two patients, blue dye in 18 and green dye in one for the arm SLN detection. RESULTS: Stained and/or hot nodes from the arm lymphatics were identified in 15 of the 21 patients (71.4 %). Among the 15 patients who had the arm SLN identified, one patient had a metastasis at the arm SLN, and another patient had common breast and arm lymphatic drainage. CONCLUSION: Identification of the arm lymphatic drainage was possible. Since there were cases of common pathway of the arm and breast lymphatics and metastasis of the arm SLN, we cannot conclude that the arm SLN detection was safe and effective. A subsequent study for identifying the presence of two different drainage systems of the breast and arm lymphatics and confirmation of no metastasis at the arm SLN is needed.

Keyword

Arm; Breast neoplasms; Lymphedema; Sentinel lymph node biopsy

MeSH Terms

Arm
Breast
Breast Neoplasms
Colloids
Drainage
Humans
Lymph Nodes
Lymphatic System
Lymphedema
Neoplasm Metastasis
Nitriles
Pyrethrins
Sentinel Lymph Node Biopsy
Colloids
Nitriles
Pyrethrins

Reference

1. Sakorafas GH, Peros G, Cataliotti L, Vlastos G. Lymphedema following axillary lymph node dissection for breast cancer. Surg Oncol. 2006. 15:153–165.

2. Wilke LG, McCall LM, Posther KE, Whitworth PW, Reintgen DS, Leitch AM, et al. Surgical complications associated with sentinel lymph node biopsy: results from a prospective international cooperative group trial. Ann Surg Oncol. 2006. 13:491–500.

3. Schrenk P, Rieger R, Shamiyeh A, Wayand W. Morbidity following sentinel lymph node biopsy versus axillary lymph node dissection for patients with breast carcinoma. Cancer. 2000. 88:608–614.

4. Soran A, D'Angelo G, Begovic M, Ardic F, Harlak A, Samuel Wieand H, et al. Breast cancer-related lymphedema--what are the significant predictors and how they affect the severity of lymphedema? Breast J. 2006. 12:536–543.

5. Ververs JM, Roumen RM, Vingerhoets AJ, Vreugdenhil G, Coebergh JW, Crommelin MA, et al. Risk, severity and predictors of physical and psychological morbidity after axillary lymph node dissection for breast cancer. Eur J Cancer. 2001. 37:991–999.

6. Petrek JA, Senie RT, Peters M, Rosen PP. Lymphedema in a cohort of breast carcinoma survivors 20 years after diagnosis. Cancer. 2001. 92:1368–1377.

7. Mansel RE, Fallowfield L, Kissin M, Goyal A, Newcombe RG, Dixon JM, et al. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. J Natl Cancer Inst. 2006. 98:599–609.

8. Thompson M, Korourian S, Henry-Tillman R, Adkins L, Mumford S, Westbrook KC, et al. Axillary reverse mapping (ARM): a new concept to identify and enhance lymphatic preservation. Ann Surg Oncol. 2007. 14:1890–1895.

9. Nos C, Lesieur B, Clough KB, Lecuru F. Blue dye injection in the arm in order to conserve the lymphatic drainage of the arm in breast cancer patients requiring an axillary dissection. Ann Surg Oncol. 2007. 14:2490–2496.

10. Carmon M, Olsha O, Rivkin L, Spira RM, Golomb E. Intraoperative palpation for clinically suspicious axillary sentinel lymph nodes reduces the false-negative rate of sentinel lymph node biopsy in breast cancer. Breast J. 2006. 12:199–201.

11. Hama Y, Koyama Y, Urano Y, Choyke PL, Kobayashi H. Simultaneous two-color spectral fluorescence lymphangiography with near infrared quantum dots to map two lymphatic flows from the breast and the upper extremity. Breast Cancer Res Treat. 2007. 103:23–28.

12. Suami H, O'Neill JK, Pan WR, Taylor GI. Superficial lymphatic system of the upper torso: preliminary radiographic results in human cadavers. Plast Reconstr Surg. 2008. 121:1231–1239.

13. Suami H, Taylor GI, Pan WR. The lymphatic territories of the upper limb: anatomical study and clinical implications. Plast Reconstr Surg. 2007. 119:1813–1822.

14. Boneti C, Korourian S, Bland K, Cox K, Adkins LL, Henry-Tillman RS, et al. Axillary reverse mapping: mapping and preserving arm lymphatics may be important in preventing lymphedema during sentinel lymph node biopsy. J Am Coll Surg. 2008. 206:1038–1042.

15. Sevick-Muraca EM, Sharma R, Rasmussen JC, Marshall MV, Wendt JA, Pham HQ, et al. Imaging of lymph flow in breast cancer patients after microdose administration of a near-infrared fluorophore: feasibility study. Radiology. 2008. 246:734–741.

16. Kitai T, Inomoto T, Miwa M, Shikayama T. Fluorescence navigation with indocyanine green for detecting sentinel lymph nodes in breast cancer. Breast Cancer. 2005. 12:211–215.

17. Uren RF, Hawman-Giles R, Thompson JF. Variation in cutaneous lymphatic flow rates. Ann Surg Oncol. 1997. 4:279–281.

18. Nos C, Kaufmann G, Clough KB, Collignon MA, Zerbib E, Cusumano P, et al. Combined axillary reverse mapping (ARM) technique for breast cancer patients requiring axillary dissection. Ann Surg Oncol. 2008. 15:2550–2555.